Evidence map›Paper›PMID 29538402›Full record

ArticlePLoS biology2018

Negative regulation of amino acid signaling by MAPK-regulated 4F2hc/Girdin complex.

Liang Weng, Yi-Peng Han, Atsushi Enomoto, Yasuyuki Kitaura, Shushi Nagamori, Yoshikatsu Kanai, Naoya Asai, Jian An, Maki Takagishi, Masato Asai and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS biology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. SLC2A9 rs16890979 reduces uric acid absorption by kidney organoids.Frontiers in cell and developmental biology · 2023
    Article
  3. Article
  4. Heteromeric Solute Carriers: Function, Structure, Pathology and Pharmacology.Advances in experimental medicine and biology · 2021
    Review
  5. Amino Acids in Cell Signaling: Regulation and Function.Advances in experimental medicine and biology · 2021
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 2 countries.

Liang WengDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yi-Peng HanDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Atsushi EnomotoDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yasuyuki KitauraDepartment of Applied Molecular Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Shushi NagamoriLaboratory of Biomolecular Dynamics, Department of Collaborative Research, Nara Medical University, Kashihara, Nara, Japan.
Yoshikatsu KanaiDepartment of Bio-System Pharmacology, Graduate School of Medicine, Osaka University, Suita, Osaka, Japan.
Naoya AsaiDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Jian AnDepartment of Respiratory Medicine, Xiangya Hospital, Central South University, Kaifu District, Changsha, China.
Maki TakagishiDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Masato AsaiDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Shinji MiiDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Takashi MasukoCell Biology Laboratory, Department of Pharmaceutical Sciences, Faculty of Pharmacy, Kindai University, Higashiosaka, Osaka, Japan.
Yoshiharu ShimomuraDepartment of Applied Molecular Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya, Japan.
Masahide TakahashiDepartment of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID 0000-0002-2803-2683
Nagoya University · JPCentral South University · CNKindai University · JPNara Medical University · JPThe University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amino acid signaling mediated by the activation of mechanistic target of rapamycin complex 1 (mTORC1) is fundamental to cell growth and metabolism. However, how cells negatively regulate amino acid signaling remains largely unknown. Here, we show that interaction between 4F2 heavy chain (4F2hc), a subunit of multiple amino acid transporters, and the multifunctional hub protein girders of actin filaments (Girdin) down-regulates mTORC1 activity. 4F2hc interacts with Girdin in mitogen-activated protein kinase (MAPK)- and amino acid signaling-dependent manners to translocate to the lysosome. The resultant decrease in cell surface 4F2hc leads to lowered cytoplasmic glutamine (Gln) and leucine (Leu) content, which down-regulates amino acid signaling. Consistently, Girdin depletion augments amino acid-induced mTORC1 activation and inhibits amino acid deprivation-induced autophagy. These findings uncovered the mechanism underlying negative regulation of amino acid signaling, which may play a role in tightly regulated cell growth and metabolism.

Indexed as

MAP Kinase Signaling SystemSignal TransductionAnimalsDown-RegulationFusion Regulatory Protein 1, Heavy ChainHeLa CellsHumansLysosomesMechanistic Target of Rapamycin Complex 1MiceMicrofilament ProteinsPhosphorylationUbiquitinationVesicular Transport ProteinsCcdc88a protein, mouseFusion Regulatory Protein 1, Heavy ChainMechanistic Target of Rapamycin Complex 1Microfilament ProteinsVesicular Transport Proteins

Identifiers

PMID29538402
PMCPMC5868845
OpenAlexW2790275611

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.